Longitudinal study of normal cognition in Parkinson disease

Neurology

Volumn 85, Issue 15, 2015, Pages 1276-1282

  Pigott, Kara ^a   Rick, Jacqueline ^a   Xie, Sharon X ^b   Hurtig, Howard ^a   Chen Plotkin, Alice ^a   Duda, John E ^a,c   Morley, James F ^a,c   Chahine, Lama M ^a   Dahodwala, Nabila ^a   Akhtar, Rizwan S ^a   Siderowf, Andrew ^d   Trojanowski, John Q ^a   Weintraub, Daniel ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d AVID RADIOPHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COGNITION; COHORT ANALYSIS; DEMENTIA; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MOTOR DYSFUNCTION; PARKINSON DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; UNIFIED PARKINSON DISEASE RATING SCALE; COGNITIVE DYSFUNCTION; COMPLICATION; DISEASE COURSE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY;

AGED; COGNITION; COGNITIVE DYSFUNCTION; DISEASE PROGRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PROSPECTIVE STUDIES;

EID: 84944383247     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000002001     Document Type: Article

References (34)

1. Weintraub D, Burn DJ. Parkinson's disease: the quintessential neuropsychiatric disorder. Mov Disord 2011; 26: 1022-1031
2. Svenningsson P, Westman E, Ballard C, Aarsland D. Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment. Lancet Neurol 2012; 11: 697-707
3. Hely MA, Reid WGJ, Adena MA, Halliday GM, Morris JGL. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 2008; 23: 837-844
4. Litvan I, Goldman JG, Troster AI, et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society task force guidelines. Mov Disord 2012; 27: 349-356
5. Winter Y, von Campenhausen S, Arend M, et al. Healthrelated quality of life and its determinants in Parkinson's disease: results from an Italian cohort study. Parkinsonism Relat Disord 2011; 17: 265-269
6. Kudlicka A, Clare L, Hindle J. Quality of life, health status and caregiver burden in Parkinson's disease: relationship to executive functioning. Int J Geriatr Psychiatry 2014; 1: 68-76
7. Pedersen K, Larsen J, Tysnes OB, Alves G. Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest Study. JAMA Neurol 2013; 70: 580-586
8. Williams-Gray CH, Foltynie T, Brayne CEG, Robbins TW, Barker RA. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain 2007; 130: 1787-1798
9. Broeders M, Velseboer D, De Bie R, et al. Cognitive change in newly-diagnosed patients with Parkinson's disease: A 5-year follow-up study. J Int Neuropsychol Soc 2013; 19: 695-708
10. Williams-Gray CH, Mason SL, Evans JR, et al. The Cam-PaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort. J Neurol Neurosurg Psychiatry 2013; 84: 1258-1264
11. Alves G, Larsen JP, Emre M, Wentzel-Larsen T, Aarsland D. Changes in motor subtype and risk for incident dementia in Parkinson's disease. Mov Disord 2006; 21: 1123-1130
12. Pfeiffer H, Lokkegaard A, Zoetmulder M, Friberg L, Wedelin L. Cognitive impairment in early-stage nondemented Parkinson's disease patients. Acta Neurol Scand 2014; 129: 307-318
13. Jacobs DM, Marder K, Côté LJ, et al. Neuropsychological characteristics of preclinical dementia in Parkinson's disease. Neurology 1995; 45: 1691-1696
14. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184
15. McKeith IG, Dickson DS, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology 2005; 65: 1863-1872
16. Jurica PJ, Leitten SL, Mattis S. Dementia Rating Scale-2 (DRS-2): Professional Manual. Odessa, FL: Psychological Assessment Resources; 2001
17. Matteau E, Dupre N, Langlois M, Provencher P, Simard M. Clinical validity of the Mattis Dementia Rating Scale-2 in Parkinson disease with MCI and dementia. J Geriatr Psychiatry Neurol 2012; 25: 100-106
18. Weintraub D, Oehlberg KA, Katz IR, Stern MB. Test characteristics of the 15-item Geriatric Depression Scale and Hamilton Depression Rating Scale in Parkinson's disease. Am J Geriatr Psychiatry 2006; 14: 169-175
19. Watson GS, Cholerton BA, Gross RG, et al. Neuropsychologic assessment in collaborative Parkinson's disease research: A proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udally Centers of Excellence for Parkinson's Disease Research at the University of Pennsylvania and the University of Washington. Alzheimers Dement 2013; 9: 609-614
20. Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007; 22: 1689-1707
21. Landis J, Koch G. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174
22. Bender R, Lange S. Adjusting for multiple testing: when and how?. J Clin Epidemiol 2001; 54: 343-349
23. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sørensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 2003; 60: 387-392
24. Janvin CC, Larsen JP, Aarsland D, Hugdahl K. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Mov Disord 2006; 21: 1343-1349
25. Kehagia AA, Barker RA, Robbins TW. Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in Parkinson's disease. Lancet Neurol 2010; 9: 1200-1213
26. Mitchell AJ, Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia: meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand 2009; 119: 252-265
27. Szewczyk-Krolikowski K, Tomlinson P, Nithi K, et al. The influence of age and gender on motor and non-motor features of early Parkinson's disease: initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort. Parkinsonism Relat Disord 2014; 20: 99-105
28. Williams-Gray CH, Evans JR, Goris A, et al. The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain 2009; 132: 2958-2969
29. Geda Y, Roberts R, Mielke M, et al. Baseline neuropsychiatric symptoms and the risk of incident mild cognitive impairment: A population-based study. Am J Psychiatry 2014; 171: 572-581
30. Xie A, Gao J, Xu L, Meng D. Shared mechanisms of neurodegeneration in Alzheimer's and Parkinson's disease. Biomed Res Int 2014; 2014: 648740
31. Burn D, Rowan E, Allan L, Molloy S, O'Brien J, McKeith I. Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2006; 77: 585-589
32. Verhhese J, Ayers E, Barzilai N, et al. Motoric cognitive risk syndrome: multicenter incidence study. Neurology 2014; 88: 2278-2284
33. Morley JF, Xie SX, Hurtig HI, et al. Genetic influences on cognitive decline in Parkinson's disease. Mov Disord 2012; 27: 512-518
34. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010; 25: 2649-2653